US Clinical Decision Support Systems Market, Forecast to 2021

Connected Healthcare Expected to Drive Growth
Share this:
     
Published: 18 May 2017

Clinical Decision Support Systems and services have evolved from being an authoritative content market dominated by large Scientific, Medical, and Technical (STM) publishers to being a dynamic and evolving connected infrastructure that includes digital workflow, electronic health record (EHR), and a variety of point-of-care solutions. While clinical guidelines and protocols remain critical components of this market, the landscape now includes a mix of suppliers, including medical device manufacturers and cloud-based clinical surveillance tools. The overall CDSS market is expected to grow by a CAGR of 8.9% from 2016 to 2021. Point-of-care solutions will be a key area of market growth. EHR providers will strive to become the hub of a CDSS, either by integrating access to CDS sources from within the EHR or through links to sources that have partnering agreements with the EHR provider. Workflow solutions, such as Computerized Physician Order Entry Systems (CPOE), documentation and scheduling sources, in addition to charge capture capabilities are also important in the market. One exciting aspect of CDSS in the digital era is the growing volume of patient data derived from medical devices, and monitoring systems, both from within the hospital and remotely. Additional scores of data signal expanded opportunities for new data analytics systems and models. This growing cache of medical data should support breakthroughs in Population Health Management Systems. Perhaps, the most exciting segment within CDSS is clinical surveillance systems that are capable of spotting serious patient-related issues with even more reliability than expert medical staffers. These systems use advanced data models to spot, at the point-of-care, nuances among the complex mix of medical indicators that may signal the prelude for a serious-yet-preventable medical event. This report also covers an array of established and new industry participants offering services in the segments covered, such as Wolters Kluwer, Zynx Health, The American College of Radiology, athenahealth, Philips, Elsevier, HCA, Premier, IBM (Truven), Inovalon, eClinical Works, Epic, Meditech, Perigen, Isabel Health, Motive Medical Intelligence, and many others. Major questions this research will answer include: • What are the major trends impacting the CDSS space? • What are the major participants across CDSS and by market segment? • What are the competitive dynamics of the CDSS market? • What is the revenue outlook for CDSS and the major segments? • What are the strategic imperatives and calls to action that will define growth and success within the CDSS market over the next five years? Frost & Sullivan predicts that CDSS will evolve to become advanced predictive analytic tools, based on input from a patient’s history, next-generation sequencing, and patient-generated data. Complex machine learning algorithms, artificial intelligence, and cognitive computing will influence advances in CDSS over the coming decades. The report also predicts the growing importance for patients to have access to CDSS from reliable medical-grade sources.

  1.  
  2.  
  3.  
  4.  
  5.  
  6.  
  7.  
  8.  
  9.  
  10.  
  11.  

Tools

Features of this research

SUBSCRIPTIONS

Help Desk

Full list of offices


For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..